Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Final price concessions for May 2024 revealed

Final price concessions for May 2024 revealed

The changes come amidst concerns over government-imposed alterations aimed at managing purchase margins

The Department of Health and Social Care (DHSC) has revised concession prices for four products and confirmed three further price concessions for May 2024.


This announcement comes in response to representations made by Community Pharmacy England (CPE) on behalf of community pharmacy owners

Concession prices have been redetermined for Ezetimibe 10mg tablets, Quetiapine 100mg tablets, Quetiapine 150mg tablets and Quetiapine 200mg tablets.

Here are the revised prices:

  • Ezetimibe 10mg tablets (28 tablets): £7.02 (previously £6.17)
  • Quetiapine 100mg tablets (60 tablets): £3.25 (previously £2.27)
  • Quetiapine 150mg tablets (60 tablets): £5.20 (previously £3.10)
  • Quetiapine 200mg tablets (60 tablets): £5.49 (previously £5.20)

Additional price concessions have been issued for Nicorandil 10mg tablets, Nicorandil 20mg tablets, and Pregabalin 75mg capsules.

Here are the newly granted concessions:

  • Nicorandil 10mg tablets (60 tablets): £5.05
  • Nicorandil 20mg tablets (60 tablets): £9.30
  • Pregabalin 75mg capsules (56 capsules): £1.54

The revised prices will be applicable to prescriptions submitted for payment during the dispensing month of May 2024, and do not apply to June 2024 prescriptions, the CPE noted.

The move follows DHSC's recent decision to impose changes to concession pricing starting from April 2024, aimed at managing purchase margins.

In the April 2024 Drug Tariff, the department announced its decision to manage retained buying margin by limiting concessionary prices. From April to June 2024, DHSC aims to recover approximately £5.4m per month from the community pharmacy sector by squeezing price concessions.

The CPE strongly opposed these “untested” changes, which were imposed by the government without their agreement.

It has been warning that putting further pressure on pharmacies to “dispense at a loss” will have very serious consequences for the sector, patients and the wider primary care system.

More For You

St James's University Hospital , NHS

Care Quality Commission downgraded the maternity and neonatal services at St James's University Hospital and Leeds General Infirmary.

Getty images

Two Leeds maternity units downgraded after inspection

The NHS regulator has downgraded two hospitals in Leeds to "inadequate" from "good" following an inspection.

The Care Quality Commission (CQC) said the maternity and neonatal services at Leeds General Infirmary (LGI) and St James' University Hospital of the Leeds Teaching Hospitals (LTH) NHS Trust posed "a significant risk" to women and babies.

Keep ReadingShow less
Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Primary care leaders join forces in effort to 'transform investment into primary care'

Community Pharmacy England (CPE) has teamed up with other national primary care bodies to urge the government to allocate more funds towards the sector.

In a joint statement released on the back of the government’s spending review, last week, the organisations welcomed the government’s continued determination to ‘shift care from hospitals to community and from sickness to prevention’ but warned that this would not be possible ‘without further investment in primary care’.

Keep ReadingShow less
Cancer patients warned against using weight-loss jabs

Macmillan Cancer Support said there is not enough evidence on how the weight-loss jabs might affect anti-cancer treatments.

iStock

Cancer patients warned against using weight-loss jabs

Cancer patients have been advised to consult their doctor before taking any weight-loss jabs.

Macmillan Cancer Support has issued this advisory following a surge in calls by cancer patients asking whether they can take fat loss jabs such as Wegovy and Mounjaro.

Keep ReadingShow less
Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology

The FLOWRx auto hub in the new Kamson warehouse in Uckfield.

Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology


Kamsons Pharmacy has announced that it has implemented a state-of-the-art hub and spoke dispensing model with the aim of freeing up more time to deliver clinical services.

Keep ReadingShow less
RPS group aims to tackle barriers holding back black pharmacy students

Work is underway to improve inclusivity in teaching

Pic credit: iStock

RPS group aims to tackle barriers holding back black pharmacy students

A cross-sector group aimed at tackling barriers that block the progression of black students and trainee pharmacists held its first meeting this week.

The Royal Pharmaceutical Society (RPS) has created the Differential Attainment Oversight Group to address issues that black or black British African student pharmacists and foundation trainees face such as limited access to work experience, financial support and visible role models in education and training.

Keep ReadingShow less